PharmaShots | Incisive News in 3 Shots

Subscribe Now

Clinical Hold

The US FDA Lifts the Clinical Hold of Protagonist's Rusfertide Clinical Development Program

The US FDA Lifts the Clinical Hold of Protagonist's Rusfertide Clinical Development Program

October 12, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us